{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:17:58Z","timestamp":1776100678267,"version":"3.50.1"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007195","name":"University of Naples Federico II","doi-asserted-by":"publisher","award":["20223PBYZB"],"award-info":[{"award-number":["20223PBYZB"]}],"id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.lfs.2024.123071","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T21:36:14Z","timestamp":1726868174000},"page":"123071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Insight into adenosine pathway in psoriasis: Elucidating its role and the potential therapeutical applications"],"prefix":"10.1016","volume":"357","author":[{"given":"Caterina","family":"Giraulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Plaitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Cicala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123071_bb0005","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2, fasc. 1","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.lfs.2024.123071_bb0010","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20, fasc. 6","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31, fasc. 2","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"10.1016\/j.lfs.2024.123071_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.lfs.2024.123071_bb0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361, fasc. 5","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.123071_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7, fasc. 1","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.lfs.2024.123071_bb0035","doi-asserted-by":"crossref","first-page":"C1757","DOI":"10.1152\/ajpcell.00147.2022","article-title":"Neuroendocrine signaling in the skin with a special focus on the epidermal neuropeptides","volume":"323, fasc. 6","author":"Slominski","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.lfs.2024.123071_bb0040","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/jdv.19257","article-title":"Polymorphisms in corticotrophin-releasing hormone\u2013proopiomalanocortin (CRH\u2013POMC) system genes: Neuroimmune contributions to psoriasis disease","volume":"37, fasc. 10","author":"Galimova","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.lfs.2024.123071_bb0045","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.3390\/ijms222112035","article-title":"Angiogenesis in chronic inflammatory skin disorders","volume":"22, fasc. 21","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tips.2016.02.006","article-title":"Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?","volume":"37, fasc. 6","author":"Borea","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0055","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414, fasc. 6866","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123071_bb0060","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13, fasc. 12","author":"Antonioli","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2024.123071_bb0065","series-title":"Adenosine Receptors in Health and Disease, vol. 193, C. N. Wilson e S. J. Mustafa, A c. di, in Handbook of Experimental Pharmacology","first-page":"383","article-title":"Adenosine receptors in wound healing, fibrosis and angiogenesis","volume":"193","author":"Feoktistov","year":"2009"},{"key":"10.1016\/j.lfs.2024.123071_bb0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0002-9440(10)61151-0","article-title":"Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A2A receptors","volume":"160, fasc. 6","author":"Montesinos","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.123071_bb0075","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fimmu.2020.01310","article-title":"Inflammatory bowel diseases: it\u2019s time for the adenosine system","volume":"11","author":"Antonioli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jid.2011.344","article-title":"Purinergic signaling in healthy and diseased skin","volume":"132, fasc. 3 Pt 1","author":"Burnstock","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejphar.2013.06.033","article-title":"Adenosine signaling in airways: toward a promising antiasthmatic approach","volume":"714, fasc. 1\u20133","author":"Cicala","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","article-title":"Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases","volume":"13, fasc. 1","author":"Cronstein","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: therapeutic aspects for inflammatory and immune diseases","volume":"7, fasc. 9","author":"Hask\u00f3","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2024.123071_bb0100","article-title":"The adenosinergic system in cancer","volume":"2, fasc. 1","author":"Sorrentino","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lfs.2024.123071_bb0105","article-title":"The immunomodulatory function of adenosine in sepsis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17, fasc. 10","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2024.123071_bb0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells9030785","article-title":"Focusing on adenosine receptors as a potential targeted therapy in human diseases","volume":"9, fasc. 3","author":"Effendi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.123071_bb0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.imlet.2018.03.007","article-title":"Canonical and non-canonical adenosinergic pathways","volume":"205","author":"Ferretti","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2024.123071_bb0130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade","volume":"1783, fasc. 5","author":"Yegutkin","year":"2008","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"10.1016\/j.lfs.2024.123071_bb0135","article-title":"A CD38\/CD203a\/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes","volume":"2, fasc. 9","author":"Horenstein","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.lfs.2024.123071_bb0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98, fasc. 4","author":"Mill\u00e1n","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.lfs.2024.123071_bb0145","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1523\/JNEUROSCI.0133-13.2013","article-title":"Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord","volume":"33, fasc. 27","author":"Street","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2024.123071_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16, fasc. 3","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mam.2017.01.002","article-title":"Extracellular ATP and adenosine: the Yin and Yang in immune responses?","volume":"55","author":"Faas","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.lfs.2024.123071_bb0160","article-title":"Comparison of adenosine deaminase level in serum and synovial fluid in patients with juvenile idiopathic arthritis and its relation to inflammatory acute phase reactants","volume":"27, fasc. 6","author":"Rahmani","year":"2017","journal-title":"Iran. J. Pediatr."},{"key":"10.1016\/j.lfs.2024.123071_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2021.110751","article-title":"Adenosine deaminase and cytokines associated with infectious diseases as risk factors for inflammatory arthritis and methotrexate as a potential prophylactic agent","volume":"159","author":"Srimadh Bhagavatham","year":"2022","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2024.123071_bb0170","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/138945012800564095","article-title":"Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders","volume":"13, fasc. 6","author":"Antonioli","year":"2012","journal-title":"Curr. Drug Targets"},{"issue":"fasc. 1","key":"10.1016\/j.lfs.2024.123071_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2024.123071_bb0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2003.11.006","article-title":"Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism","volume":"312, fasc. 4","author":"N\u00e9meth","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123071_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0006-291X(03)01125-2","article-title":"Adenosine A2B receptors modulate cAMP levels and induce CREB but not ERK1\/2 and p38 phosphorylation in rat skeletal muscle cells","volume":"307, fasc. 1","author":"Lynge","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123071_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0026-895X(25)14218-1","article-title":"Adenosine-induced alterations in the adenosine 3\u2032:5\u2032-monophosphate levels in mammalian epidermis","volume":"18, fasc. 1","author":"Duell","year":"1980","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2340\/0001555572253255","article-title":"A defective purine nucleotide synthesis pathway in psoriatic patients","volume":"72, fasc. 4","author":"Kiehl","year":"1992","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.lfs.2024.123071_bb0200","first-page":"274","article-title":"Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study","volume":"10, fasc. 4","author":"Bukulmez","year":"2000","journal-title":"Eur. J. Dermatol. EJD"},{"key":"10.1016\/j.lfs.2024.123071_bb0205","first-page":"137","article-title":"The effect of methotrexate on activity of T-lymphocyte marker enzymes in patients with psoriasis vulgaris","volume":"96, fasc. 3","author":"Vlcek","year":"1995","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.lfs.2024.123071_bb0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1365-2133.2001.04221.x","article-title":"Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis","volume":"144, fasc. 6","author":"Kose","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1468-3083.2009.03416.x","article-title":"Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis","volume":"24, fasc. 3","author":"Hashemi","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.lfs.2024.123071_bb0220","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4049\/jimmunol.164.2.1013","article-title":"Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock","volume":"164, fasc. 2","author":"Hask\u00f3","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0225","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.8.6.617","article-title":"Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro","author":"Marton","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2024.123071_bb0230","doi-asserted-by":"crossref","first-page":"1043970","DOI":"10.3389\/fphar.2022.1043970","article-title":"Inosine: a bioactive metabolite with multimodal actions in human diseases","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cellimm.2009.03.020","article-title":"The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn\u2019s disease","volume":"258, fasc. 2","author":"Ochaion","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19811","article-title":"Efficacy and safety of piclidenoson in plaque psoriasis: results from a randomized phase 3 clinical trial (COMFORT-1)","author":"Papp","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV, gen."},{"key":"10.1016\/j.lfs.2024.123071_bb0245","doi-asserted-by":"crossref","first-page":"2310970","DOI":"10.1155\/2018\/2310970","article-title":"Inhibition of IL-17 and IL-23 in human keratinocytes by the A3 adenosine receptor agonist piclidenoson","volume":"2018","author":"Cohen","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.lfs.2024.123071_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jid.2016.07.028","article-title":"Adenosine A2A and A2B receptors differentially modulate keratinocyte proliferation: possible deregulation in psoriatic epidermis","volume":"137, fasc. 1","author":"Andr\u00e9s","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0255","article-title":"Phenotypical analysis of ectoenzymes CD 39\/CD 73 and adenosine receptor 2A in CD 4 + CD 25 high Foxp3 + regulatory T-cells in psoriasis","volume":"59, fasc. 1","author":"Han","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0260","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.tcb.2021.05.008","article-title":"The elegant complexity of mammalian ecto-5\u2032-nucleotidase (CD73)","volume":"31, fasc. 10","author":"Alcedo","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00011-023-01820-1","article-title":"Ecto-5\u2032-nucleotidase (CD73): an emerging role as prognostic factor in allergic sensitization","volume":"73, fasc. 1","author":"Morello","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2024.123071_bb0270","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2174\/138161209788186335","article-title":"Purinergic receptors and pain","volume":"15, fasc. 15","author":"Burnstock","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2024.123071_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrg758","article-title":"Getting under the skin of epidermal morphogenesis","volume":"3, fasc. 3","author":"Fuchs","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.lfs.2024.123071_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13, fasc. 1","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2024.123071_bb0290","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrm3175","article-title":"Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis","volume":"12, fasc. 9","author":"Simpson","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ceb.2014.12.008","article-title":"Keratins in health and disease","volume":"32","author":"Toivola","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1523-1747.2001.01327.x","article-title":"Keratins and the keratinocyte activation cycle","volume":"116, fasc. 5","author":"Freedberg","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0305","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/cells8080807","article-title":"Keratin 6, 16 and 17\u2014critical barrier alarmin molecules in skin wounds and psoriasis","volume":"8, fasc. 8","author":"Zhang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.123071_bb0310","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/er.2012-1092","article-title":"Key role of CRF in the skin stress response system","volume":"34, fasc. 6","author":"Slominski","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2024.123071_bb0315","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.steroids.2015.04.006","article-title":"On the role of skin in the regulation of local and systemic steroidogenic activities","volume":"103","author":"Slominski","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.lfs.2024.123071_bb0320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41435-020-0096-6","article-title":"Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders","volume":"21, fasc. 3","author":"Slominski","year":"2020","journal-title":"Genes Immun."},{"key":"10.1016\/j.lfs.2024.123071_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111238","article-title":"The significance of CYP11A1 expression in skin physiology and pathology","volume":"530","author":"Slominski","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123071_bb0330","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397, fasc. 10281","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2024.123071_bb0335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1743-6109.2006.00105.x","article-title":"Purinergic substances promote murine keratinocyte proliferation and enhance impaired wound healing in mice","volume":"14, fasc. 2","author":"Braun","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.lfs.2024.123071_bb0340","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1523-1747.2000.00145.x","article-title":"Adenosine- and adenine-nucleotide-mediated inhibition of Normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport","volume":"115, fasc. 5","author":"Brown","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0345","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/jpet.117.244319","article-title":"Adenosine A2A receptor agonist, 2-p-(2-carboxyethyl)phenethylamino-5\u2032-N-ethylcarboxamidoadenosine hydrochloride hydrate, inhibits inflammation and increases fibroblast growth factor-2 tissue expression in carrageenan-induced rat paw edema","volume":"364, fasc. 2","author":"Ialenti","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2024.123071_bb0350","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jid.2021.07.174","article-title":"Positive allosteric modulation of A2AR alters immune cell responses and ameliorates psoriasis-like dermatitis in mice","volume":"142, fasc. 3, Part A","author":"Welihinda","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0355","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/ijms23031455","article-title":"The discovery and function of Filaggrin","volume":"23, fasc. 3","author":"Hoober","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116401","article-title":"Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia","volume":"173","author":"Mar\u00edn-Castej\u00f3n","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.123071_bb0365","article-title":"Skin barrier dysregulation in psoriasis","volume":"22, fasc. 19, Art. fasc. 19","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0370","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-9440(10)63346-9","article-title":"Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures","volume":"165, fasc. 3","author":"Lippens","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.123071_bb0375","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/ijms19010179","article-title":"Scanning the Immunopathogenesis of psoriasis","volume":"19, fasc. 1","author":"Chiricozzi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0380","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32, fasc. 1","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0385","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184, fasc. 1","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0390","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: a comprehensive review","volume":"50, fasc. 3","author":"Deng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.lfs.2024.123071_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in psoriasis","volume":"10","author":"Chiang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0400","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00403-013-1404-z","article-title":"Psoriatic keratinocytes prime neutrophils for an overproduction of superoxide anions","volume":"305, fasc. 10","author":"Gu\u00e9rard","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.lfs.2024.123071_bb0405","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fimmu.2019.00746","article-title":"Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk","volume":"10","author":"Shao","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0410","doi-asserted-by":"crossref","first-page":"31119","DOI":"10.1038\/srep31119","article-title":"Neutrophil extracellular trap formation is increased in psoriasis and induces human \u03b2-defensin-2 production in epidermal keratinocytes","volume":"6, fasc. 1","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.123071_bb0415","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187, fasc. 1","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0420","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jid.2019.04.020","article-title":"Psoriasis caught in the NET","volume":"139, fasc. 7","author":"Di Domizio","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0425","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jid.2018.11.021","article-title":"Neutrophil extracellular traps induce human Th17 cells: effect of psoriasis-associated TRAF3IP2 genotype","volume":"139, fasc. 6","author":"Lambert","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0430","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/ATVBAHA.111.226845","article-title":"Regulation of neutrophil function by adenosine","volume":"32, fasc. 4","author":"Barletta","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0435","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/JLB.3VMA0918-374R","article-title":"Adenosine from a biologic source regulates neutrophil extracellular traps (NETs)","volume":"105, fasc. 6","author":"Xu","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0440","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11302-022-09884-0","article-title":"A2A adenosine receptor activation prevents neutrophil aging and promotes polarization from N1 towards N2 phenotype","volume":"18, fasc. 3","author":"Lov\u00e1szi","year":"2022","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2024.123071_bb0445","doi-asserted-by":"crossref","first-page":"1022986","DOI":"10.3389\/fimmu.2022.1022986","article-title":"Mast cells as important regulators in the development of psoriasis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0450","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbrc.2017.04.141","article-title":"Th17 cell-mediated immune responses promote mast cell proliferation by triggering stem cell factor in keratinocytes","volume":"487, fasc. 4","author":"Cho","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123071_bb0455","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jid.2020.07.027","article-title":"An autocrine circuit of IL-33 in keratinocytes is involved in the progression of psoriasis","volume":"141, fasc. 3","author":"Zeng","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0460","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/ced.12086","article-title":"Serum IgE levels are increased in patients with generalized pustular psoriasis","volume":"38, fasc. 5","author":"Ding","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0465","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.alit.2018.03.007","article-title":"The role of adenosine for IgE receptor-dependent degranulation of human peripheral basophils and skin mast cells","volume":"67, fasc. 4","author":"Matsuo","year":"2018","journal-title":"Allergol. Int."},{"key":"10.1016\/j.lfs.2024.123071_bb0470","doi-asserted-by":"crossref","first-page":"16887","DOI":"10.1016\/S0021-9258(19)85277-8","article-title":"The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells","volume":"268, fasc. 23","author":"Ramkumar","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123071_bb0475","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10875-011-9517-7","article-title":"Disparity in Fc\u03b5RI-induced degranulation of primary human lung and skin mast cells exposed to adenosine","volume":"31, fasc. 3","author":"Gomez","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0480","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11302-014-9409-4","article-title":"The role of activated adenosine receptors in degranulation of human LAD2 mast cells","volume":"10, fasc. 3","author":"Leung","year":"2014","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2024.123071_bb0485","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(02)02645-6","article-title":"A role for histamine in cytokine modulation by the adenosine A3 receptor agonist, 2-Cl-IB-MECA","volume":"457, fasc. 1","author":"Smith","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941071","article-title":"Dendritic cells and macrophages in the pathogenesis of psoriasis","volume":"13","author":"Kamata","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0495","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1346-8138.14733","article-title":"Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization","volume":"46, fasc. 2","author":"Kim","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0500","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2007.06.006","article-title":"Targeting TNF\u03b1 rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation","volume":"48, fasc. 2","author":"Marble","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0505","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jdermsci.2018.05.009","article-title":"Treatment with TNF-\u03b1 inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation","volume":"91, fasc. 3","author":"Lin","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0510","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)63698-X","article-title":"An Angiogenic switch in macrophages involving synergy between toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors","volume":"163, fasc. 2","author":"Pinhal-Enfield","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.123071_bb0515","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2007-01-065870","article-title":"A2A adenosine receptors and C\/EBP\u03b2 are crucially required for IL-10 production by macrophages exposed to Escherichia coli","volume":"110, fasc. 7","author":"Cs\u00f3ka","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2024.123071_bb0520","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-alpha production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14, fasc. 13","author":"Hasko","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2024.123071_bb0525","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/jpet.105.096016","article-title":"Adenosine inhibits tumor necrosis factor-\u03b1 release from mouse peritoneal macrophages via A 2A and A 2B but not the a 3 adenosine receptor","volume":"317, fasc. 1","author":"Kreckler","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2024.123071_bb0530","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.4049\/jimmunol.175.12.8260","article-title":"Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism","volume":"175, fasc. 12","author":"N\u00e9meth","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0535","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1096\/fj.08-107458","article-title":"Adenosine A 2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function","volume":"22, fasc. 10","author":"Cs\u00f3ka","year":"2008","journal-title":"FASEB J."},{"issue":"fasc. 2","key":"10.1016\/j.lfs.2024.123071_bb0540","article-title":"Differential macrophage activation alters the expression profile of NTPDase and ecto-5\u2032-nucleotidase","volume":"7","author":"Zanin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2024.123071_bb0545","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.jid.5700286","article-title":"The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion","volume":"126, fasc. 6","author":"Sch\u00f6n","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110309","article-title":"Adenosine A2A receptor activation regulates the M1 macrophages activation to initiate innate and adaptive immunity in psoriasis","volume":"266","author":"Lu","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0555","article-title":"Cutaneous immune responses mediated by dendritic cells and mast cells","volume":"4, fasc. 1","author":"Sumpter","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.lfs.2024.123071_bb0560","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2008-02-136325","article-title":"Adenosine receptors in regulation of dendritic cell differentiation and function","volume":"112, fasc. 5","author":"Novitskiy","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2024.123071_bb0565","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/imm.12053","article-title":"Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8 + T-cell priming capacity","volume":"138, fasc. 4","author":"Challier","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2024.123071_bb0570","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jid.2018.10.016","article-title":"Production of extracellular adenosine by CD73+ dendritic cells is crucial for induction of tolerance in contact hypersensitivity reactions","volume":"139, fasc. 3","author":"Silva-Vilches","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper T cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0580","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174, fasc. 1","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0585","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity","volume":"135, fasc. 1","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0590","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biopha.2017.06.055","article-title":"MiR-200a expression in CD4+ T cells correlates with the expression of Th17\/Treg cells and relevant cytokines in psoriasis vulgaris: a case control study","volume":"93","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.123071_bb0595","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/sji.12404","article-title":"Characterization of Th17 and FoxP3 + Treg cells in paediatric psoriasis patients","volume":"83, fasc. 3","author":"Zhang","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0600","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/09674845.2016.1207869","article-title":"Immunophenotyping of T cells in the peripheral circulation in psoriasis","volume":"73, fasc. 4","author":"Priyadarssini","year":"2016","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0605","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1189\/JLB.0109046","article-title":"IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines","volume":"86, fasc. 2","author":"Ortega","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0610","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35, fasc. 4","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2024.123071_bb0615","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/ATVBAHA.111.226837","article-title":"Regulation of lymphocyte function by adenosine","volume":"32, fasc. 9","author":"Linden","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2024.123071_bb0620","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fimmu.2019.00162","article-title":"Adenosine A2A receptor stimulation inhibits TCR-induced Notch1 activation in CD8+T-cells","volume":"10","author":"Sorrentino","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0625","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1182\/blood-2004-04-1407","article-title":"Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo","volume":"105, fasc. 12","author":"Erdmann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2024.123071_bb0630","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204, fasc. 6","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.123071_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00190","article-title":"The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway","volume":"3","author":"Ohta","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0640","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/ced.12497","article-title":"Target tissue ectoenzyme CD39\/CD73-expressing Foxp3 + regulatory T cells in patients with psoriasis","volume":"40, fasc. 2","author":"Zhang","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0645","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bjd.16560","article-title":"Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73\/AMPK\/mTOR pathway","volume":"179, fasc. 4","author":"Yan","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0650","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.4049\/jimmunol.1100117","article-title":"The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6","volume":"186, fasc. 12","author":"Wilson","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0655","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4049\/jimmunol.1103721","article-title":"Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation","volume":"190, fasc. 1","author":"Wei","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0660","article-title":"Extracellular adenosine induces hypersecretion of IL-17A by T-helper 17 cells through the adenosine A2a receptor","volume":"26","author":"Tokano","year":"2022","journal-title":"Brain Behav. Immun. - Health"},{"key":"10.1016\/j.lfs.2024.123071_bb0665","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/25785826.2022.2094593","article-title":"Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4+ T-cell hypersecretion of IL-17A and IL-8 in humans","volume":"45, fasc. 4","author":"Tokano","year":"2022","journal-title":"Immunol. Med."},{"key":"10.1016\/j.lfs.2024.123071_bb0670","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/imm.13608","article-title":"Adenosine signalling in T-cell activation favours development of IL-17 positive cells with suppressive properties","volume":"169, fasc. 1","author":"Leikeim","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2024.123071_bb0675","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90, fasc. 3","author":"Heidenreich","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.lfs.2024.123071_bb0680","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mjd.2003.89","article-title":"Papillary tip bleeding or the Auspitz phenomenon: a hero wrongly credited and a misnomer resolved","volume":"48, fasc. 2","author":"Holubar","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0685","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/exd.14329","article-title":"Increased angiogenesis and migration of dermal microvascular endothelial cells from patients with psoriasis","volume":"30, fasc. 7","author":"Li","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0690","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1365-2133.2010.09990.x","article-title":"Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris","volume":"163, fasc. 5","author":"Anderson","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0695","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1346-8138.16588","article-title":"Serum levels of angiogenesis-related factors in patients with psoriasis","volume":"50, fasc. 2","author":"Watanabe","year":"2023","journal-title":"J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0700","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bcp.2008.11.002","article-title":"Adenosine receptor agonists for promotion of dermal wound healing","volume":"77, fasc. 7","author":"Valls","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0705","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000012203.21416.14","article-title":"Differential expression of adenosine receptors in human endothelial cells","volume":"90, fasc. 5","author":"Feoktistov","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2024.123071_bb0710","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.HYP.0000144800.21037.a5","article-title":"Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A 2B angiogenic phenotype","volume":"44, fasc. 5","author":"Feoktistov","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2024.123071_bb0715","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.4049\/jimmunol.171.8.3991","article-title":"Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells","volume":"171, fasc. 8","author":"Khoa","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0720","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1177\/1535370215584939","article-title":"Adenosine A 2B receptor stimulates angiogenesis by inducing VEGF and eNOS in human microvascular endothelial cells","volume":"240, fasc. 11","author":"Du","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2024.123071_bb0725","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.104.007807","article-title":"Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1","volume":"67, fasc. 5","author":"Desai","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0730","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0002-9440(10)63749-2","article-title":"Adenosine A2A receptor activation promotes wound neovascularization by stimulating angiogenesis and Vasculogenesis","volume":"164, fasc. 6","author":"Montesinos","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2024.123071_bb0735","series-title":"Adenosine A2A Receptor Agonists Promote more Rapid Wound Healing than Recombinant Human Platelet\u2013Derived Growth Factor (Becaplermin Gel)","first-page":"19","volume":"26","author":"Victor-Vega","year":"2002"},{"key":"10.1016\/j.lfs.2024.123071_bb0740","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s10753-015-0184-3","article-title":"Promotion of wound healing by an agonist of adenosine A2A receptor is dependent on tissue plasminogen activator","volume":"38, fasc. 6","author":"Montesinos","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2024.123071_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.654104","article-title":"Annexin A2-mediated plasminogen activation in endothelial cells contributes to the proangiogenic effect of adenosine A2A receptors","volume":"12","author":"Valls","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123071_bb0750","article-title":"Targeting adenosine A2A receptors for early intervention of retinopathy of prematurity","author":"Chen","year":"2024","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2024.123071_bb0755","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41467-017-00551-2","article-title":"Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis","volume":"8, fasc. 1","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123071_bb0760","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system Physician\u2019s global assessment","volume":"51, fasc. 4","author":"Langley","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0765","article-title":"Photo-neuro-immuno-endocrinology: how the ultraviolet radiation regulates the body, brain, and immune system","volume":"121, fasc. 14","author":"Slominski","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2024.123071_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2024.04.022","article-title":"Biological effects of CYP11A1-derived vitamin D and lumisterol metabolites in the skin","author":"Slominski","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0775","first-page":"1","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8, fasc. 1","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2024.123071_bb0780","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/PTT.S294173","article-title":"Key signaling pathways in psoriasis: recent insights from Antipsoriatic therapeutics","volume":"Volume 11","author":"Ben Abdallah","year":"2021","journal-title":"Psoriasis Targets Ther."},{"key":"10.1016\/j.lfs.2024.123071_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115184","article-title":"Drugs targeting adenosine signaling pathways: a current view","volume":"165","author":"Kutryb-Zaj\u0105c","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.123071_bb0790","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/ph13090260","article-title":"Adenosine signaling in autoimmune disorders","volume":"13, fasc. 9","author":"Magni","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.lfs.2024.123071_bb0795","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16, fasc. 3","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"fasc. 3","key":"10.1016\/j.lfs.2024.123071_bb0800","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1529-0131(200003)43:3<656::AID-ANR23>3.0.CO;2-H","volume":"43","author":"Montesinos","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2024.123071_bb0805","first-page":"87","article-title":"Advances in the use of topical imiquimod to treat dermatologic disorders","volume":"4, fasc. 1","author":"Lacarrubba","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.lfs.2024.123071_bb0810","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.0366-077X.2003.05628.x","article-title":"Imiquimod: modes of action","volume":"149, fasc. s66","author":"Sauder","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0815","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.0906-6705.2006.00414.x","article-title":"Immune response modifiers\u2014mode of action","volume":"15, fasc. 5","author":"Schiller","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.lfs.2024.123071_bb0820","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 Axis","volume":"182, fasc. 9","author":"Van Der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123071_bb0825","series-title":"Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II\/III Multicenter, Randomized, Controlled Trial","volume":"15, fasc. 8","author":"David","year":"2016"},{"key":"10.1016\/j.lfs.2024.123071_bb0830","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-3083.2011.04078.x","article-title":"Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial","volume":"26, fasc. 3","author":"David","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.lfs.2024.123071_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105731","article-title":"Optical control of adenosine A3 receptor function in psoriasis","volume":"170","author":"L\u00f3pez-Cano","year":"2021","journal-title":"Pharmacol. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524006611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524006611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:21:44Z","timestamp":1776097304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524006611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":167,"alternative-id":["S0024320524006611"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123071","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into adenosine pathway in psoriasis: Elucidating its role and the potential therapeutical applications","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123071"}}